Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation (2013 - 2025)

Corbus Pharmaceuticals Holdings' Share-based Compensation history runs 13 years deep, the most recent figure standing at $8.3 million for Q3 2025.

• On a quarterly basis, Share-based Compensation rose 369940.12% year-over-year to $8.3 million in Q3 2025; TTM through Sep 2025 was $8.3 million, a 365.11% increase from a year earlier, with the FY2024 full-year figure at $6.1 million, up 77.09% from the prior year.
• Share-based Compensation advanced to $8.3 million in Q3 2025 per CRBP's latest filing, from $1563.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $8.3 million in Q3 2025 and bottomed at $1288.0 in Q2 2024.
• The 5-year median for Share-based Compensation is $1.3 million (2022), against an average of $1.6 million.
• Across the five-year window, Share-based Compensation sank 99.84% in 2024 and surged 369940.12% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $1.8 million in 2021, then dropped by 29.23% to $1.3 million in 2022, then plunged by 37.05% to $799000.0 in 2023, then jumped by 104.26% to $1.6 million in 2024, then surged by 408.58% to $8.3 million in 2025.
• Per Business Quant, the three latest CRBP Share-based Compensation figures stand at $8.3 million (Q3 2025), $1563.0 (Q2 2025), and $1.7 million (Q1 2025).